Overview

Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics

Status:
Completed

Trial end date:
2005-09-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.

Phase:

Phase 2

Details

Lead Sponsor:

Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products, R&D Inc.

Treatments:

Bronchodilator Agents